Psychedelic Investor TV

To appear on an upcoming episode on Psychedelic Investor TV in conjunction with New to the Street TV airing on News Max, contact Roland Rick Perry at 310-594-8062 or [email protected]

Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on Good Morning America.

News Channel 5 Nashville. Ketamine infusions are being used to treat patients with severe depression. The medicine is also a treatment for curb substance abuse addictions.

KCSA Psychedelics Conference. Wednesday, October 13th.

The KCSA Psychedelics Conference features live presentations and speakers who will address the various investment opportunities in psychedelic treatments for mental health disorders.

Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale. Interview start at 10:00 mark. LIVE QUOTE It had been a long descent lower for AdvisorShares...

Conference: Replay of Advances in Mental Health. M-Vest & Maxim Group LLC.

One of the best Conferences we have viewed to date, and being on replay it can be viewed at your leisure and/or paused - for when your broker calls with...

Video: Business TV News Featured companies: Entheon Biomedical Corp. (CSE: ENBI, OTCQB: ENTBF)Researching and developing DMT, one of the most powerful of its kind in...

Psychedelics Space is Just Getting Started: Field Trip Health (FTRP) Chairman, Ronan Levy.

Ronan Levy, Field Trip Health Chairman, joins Yahoo Finance to discuss the psychedelic company’s debut on the Nasdaq and the development of the psychedelics. VIDEO
Most Popular

Awakn Life Sciences (AWKNF) $0.30 Announces Signing of Lease for Second Clinic in Norway.

Trondheim in central Norway will be the location of Awakn's 4th clinic LIVE QUOTE

Silo Pharma (SILO) Issues Letter to Shareholders

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE QUOTE

Silo Pharma (SILO) $3.36 Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation

View Post ENGLEWOOD CLIFFS, NJ, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage...